From drug development and clinical research to commercial manufacturing and release testing, our Pharma Assay Development (PAD) technical experts can provide the end-to-end support needed to fuel your precision medicine and cell and gene therapy, through custom single-cell multi-omic analysis on the Tapestri platform.
Rare cell detection, tracking clonal heterogeneity, and determining zygosity and co-occurence of edits at the single-cell level are all critical to the development and commercialization of personalized therapeutics. Partnering with PAD is the only solution to accessing these multi-parametric datasets on a single platform. Biopharmaceutical companies, both large and small, have leveraged PAD to advance their biomarker development, and cell and gene therapy pipelines.
Scope Project
Panel &
Assay Design
Wet Lab
Data Analysis
Long-term
Pipeline
Support
Panel &
Assay Design
Cells analyzed on Tapestri in-house
Novel custom assays developed and transfered to GMP
Publications world-wide from leading KOLs
PAD and IND-enabling projects with Top Global Pharma partners
If you don’t see an application that fits your needs, ask us about developing a custom solution. To date, we have produced 15 fit-for-purpose assays, with more on the way.
